Impact of clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

American Journal of Cardiology

Volumn 110, Issue 11, 2012, Pages 1598-1606

  Kim, Joon Young ^a   Jeong, Myung Ho ^b   Moon, Jae Hyun ^a   Ahn, Yong Keun ^b   Chae, Shung Chull ^c   Hur, Seung Ho ^d   Hong, Taek Jong ^e   Kim, Young Jo ^f   Seong, In Whan ^g   Chae, In Ho ^h   Cho, Myeong Chan ⁱ   Jang, Yang Soo ^j   Yoon, Jung Han ^k   Seung, Ki Bae ^l   Park, Seung Jung ^m  

^a Hanyeo Expo Hospital   (South Korea)

^b Chonnam National University   (South Korea)

^c Kyungpook National University   (South Korea)

^d Dongsan Medical Center   (South Korea)

^e Pusan National University Hospital   (South Korea)

^f Young Nam University Hospital   (South Korea)

^g Chungnam National University College of Medicine   (South Korea)

^h Seoul National University Bundang Hospital   (South Korea)

ⁱ Chungbuk National University   (South Korea)

^j Yonsei University   (South Korea)

^k Wonju Severance Christian Hospital   (South Korea)

^l The Catholic University of Korea   (South Korea)

^m Asan Medical Center   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEATH; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; SURVIVAL RATE; TICLOPIDINE;

EID: 84869083641     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.07.025     Document Type: Article

References (26)

1. J. Machecourt, N. Danchin, J.M. Lablanche, J.M. Fauvel, J.L. Bonnet, S. Marliere, A. Foote, J.L. Quesada, H. Eltchaninoff, G. Vanzetto EVASTENT Investigators Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry J Am Coll Cardiol 50 2007 501 508
2. C. Briguori, F. Airoldi, A. Chieffo, M. Carlino, M. Montorfano, A. Colombo Renal function and drug-eluting stent Int J Cardiol 142 2010 92 94
3. H.M. Sadeghi, G.W. Stone, C.L. Grines, R. Mehran, S.R. Dixon, A.J. Lansky, M. Fahy, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, T.D. Stuckey, M. Turco, J.D. Carroll Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 2003 2769 2775
4. D. Hachinohe, M.H. Jeong, S. Saito, K. Ahmed, S.H. Hwang, M.G. Lee, D.S. Sim, K.H. Park, J.H. Kim, Y.J. Hong, Y. Ahn, J.C. Kang, J.H. Kim, S.C. Chae, Y.J. Kim, S.H. Hur, I.W. Seong, T.J. Hong, D. Choi, M.C. Cho, C.J. Kim, K.B. Seung, W.S. Chung, Y.S. Jang, S.W. Rha, J.H. Bae, S.J. Park Korea Acute Myocardial Infarction Registry Investigators Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry) Am J Cardiol 108 2011 206 213
5. P.J. Best, S.R. Steinhubl, P.B. Berger, A. Dasgupta, D.M. Brennan, L.A. Szczech, R.M. Califf, E.J. Topol CREDO Investigators The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial Am Heart J 155 2008 687 693
6. A. Dasgupta, S.R. Steinhubl, D.L. Bhatt, P.B. Berger, M. Shao, K.H. Mak, A.A. Fox, G. Montalescot, M.A. Weber, S.M. Haffner, A.P. Dimas, P.G. Steg, E.J. Topol CHARISMA Investigators Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] trial) Am J Cardiol 103 2009 1359 1363
7. S.H. Park, W. Kim, C.S. Park, W.Y. Kang, S.H. Hwang, W. Kim A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure Am J Cardiol 104 2009 1292 1295
8. D.J. Angiolillo, E. Bernardo, D. Capodanno, D. Vivas, M. Sabate, J.L. Ferreiro, M. Ueno, P. Jimenez-Quevedo, F. Alfonso, T.A. Bass, C. Macaya, A. Fernandez-Ortiz Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy J Am Coll Cardiol 55 2010 1139 1146
9. G. Dangas, R. Mehran, G. Guagliumi, A. Caixeta, B. Witzenbichler, J. Aoki, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, L.E. Rabbani, H. Parise, G.W. Stone HORIZONS-AMI Trial Investigators Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 54 2009 1438 1446
10. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, A. Avezum, P. Widimsky, P.G. Steg, J.P. Bassand, G. Montalescot, C. Macaya, G. Di Pasquale, K. Niemela, A.E. Ajani, H.D. White, S. Chrolavicius, P. Gao, K.A. Fox, S. Yusuf CURRENT-OASIS 7 Trial Investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
11. I. Fuchs, M. Frossard, A. Spiel, E. Riedmuller, A.N. Laggner, B. Jilma Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J Thromb Haemost 4 2006 2547 2552
12. F. Karlsson, A. Modica, T. Mooe Dynamics of platelet activation in diabetic and non-diabetic subjects during the course of an acute myocardial infarction Thromb Res 121 2007 269 273
13. K.H. Lee, M.H. Jeong, Y.K. Ahn, J.H. Kim, S.C. Chae, Y.J. Kim, S.H. Hur, I.W. Seong, T.J. Hong, D. Choi, M.C. Cho, C.J. Kim, K.B. Seung, W.S. Chung, Y.S. Jang, J.G. Cho, S.J. Park Korea Acute Myocardial Infarction Registry Investigators Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry Int J Cardiol 130 2008 227 234
14. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
15. W. Hochholzer, D. Trenk, H.P. Bestehorn, B. Fischer, C.M. Valina, M. Ferenc, M. Gick, A. Caputo, H.J. Büttner, F.J. Neumann Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 2006 1742 1750
16. P. Buonamici, R. Marcucci, A. Migliorini, G.F. Gensini, A. Santini, R. Paniccia, G. Moschi, A.M. Gori, R. Abbate, D. Antoniucci Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2007 2312 2317
17. T. Cuisset, C. Frere, P.J. Moro, J. Quilici, C. Pons, B. Gaborit, L. Camoin, P.E. Morange, J.L. Bonnet, M.C. Alessi Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after acute coronary syndrome Thromb Res 126 2010 e400 e402
18. O. Morel, S. El Ghannudi, L. Jesel, B. Radulescu, N. Meyer, M.L. Wiesel, S. Caillard, U. Campia, B. Moulin, C. Gachet, P. Ohlmann Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel J Am Coll Cardiol 57 2011 399 408
19. P. Htun, S. Fateh-Moghadam, C. Bischofs, W. Banya, K. Müller, B. Bigalke, K. Stellos, A.E. May, M. Flather, M. Gawaz, T. Geisler Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention J Am Soc Nephrol 22 2011 627 633
20. M.J. Price, K.R. Nayak, C.M. Barker, D.E. Kandzari, P.S. Teirstein Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention Am J Cardiol 103 2009 1339 1343
21. C.U. Choi, S.W. Rha, D.J. Oh, K.L. Poddar, J.O. Na, J.W. Kim, H.E. Lim, E.J. Kim, C.G. Park, H.S. Seo, T.J. Hong, J.S. Park, Y.J. Kim, S.H. Hur, I.W. Seong, J.K. Chae, M.C. Cho, J.H. Bae, D.H. Choi, Y.S. Jang, I.H. Chae, H.S. Kim, C.J. Kim, J.H. Yoon, T.H. Ahn, S.J. Tahk, W.S. Chung, K.B. Seung, S.C. Chae, S.J. Park, Y.K. Ahn, M.H. Jeong Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insight from the Korea Acute Myocardial Infarction Registry Am Heart J 161 2011 373 382
22. S.J. Pocock, R. Mehran, T.C. Clayton, E. Nikolsky, H. Parise, M. Fahy, A.J. Lansky, M.E. Bertrand, A.M. Lincoff, J.W. Moses, E.M. Ohman, H.D. White, G.W. Stone Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 121 2010 43 51
23. J.A. Jakubowski, K.J. Winters, H. Naganuma, L. Wallentin Prasugrel: a novel thienopyridine antiplatelet agent A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile Cardiovasc Drug Rev 25 2007 357 374
24. P.A. Gurbel, K.P. Bliden, K. Butler, M.J. Antonino, C. Wei, R. Teng, L. Rasmussen, R.F. Storey, T. Nielsen, J.W. Eikelboom, G. Sabe-Affaki, S. Husted, D.J. Kereiakes, D. Henderson, D.V. Patel, U.S. Tantry Response to ticagrelor in clopidogrel nonresponders and effect of switching therapies: the RESPOND study Circulation 121 2010 1188 1199
25. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
26. S. James, A. Budaj, P. Aylward, K.K. Buck, C.P. Cannon, J.H. Cornel, R.A. Harrington, J. Horrow, H. Katus, M. Keltai, B.S. Lewis, K. Parikh, R.F. Storey, K. Szummer, D. Wojdyla, L. Wallentin Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 122 2010 1056 1067